Table of contents
December 2018 - Volume 56 - 12
Editorial
- Conditional approval: who knows? (25 October, 2018)
DTB Select
- MHRA Drug Safety Update: denosumab (Xgeva) and rebound hypercalcaemia (8 October, 2018)
- Intensive antihypertensive treatment and serious adverse events in older people (23 November, 2018)
- Omega-3 fatty acid supplements do not improve symptoms of dry eye disease (23 November, 2018)
Review
- Written information on medicines for patients: learning from the PIL (23 November, 2018)
Case report
- Case of drug-induced interstitial lung disease secondary to adalimumab (23 November, 2018)